Search
MSK medical oncologist David Straus is looking for less-intensive treatments for Hodgkin lymphoma, a type of blood cancer most commonly found in young adults.
The online resource will serve as a benchmark for researchers studying metabolism and cancer.
Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments.
Mark Denisiuk was diagnosed with acute myeloid leukemia in the spring of 2021. He found hope when he enrolled in an early trial of an entirely new kind of drug that’s based on lab research conducted at MSK.
Nine students will don caps and gowns to celebrate their academic achievements and receive their PhDs from the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK).
Discover how Sunrise Association Day Camps are transforming summer for children affected by cancer.
Hear from GSK Alumni Lindsey, Prashant, and Theresa, as they share more about their experience and where their careers have taken them.
Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.
Researchers from Memorial Sloan Kettering Cancer Center have begun testing for three new genetic targets and found that together they occur in approximately 50 percent of patients with squamous cell carcinomas of the lung, which affects 40,000 Americans each year. Initial findings of the research will be presented on June 4 at the 2012 American Society of Clinical Oncology (ASCO) Annual Meeting.
The certification comes after a year in which hundreds of experts worked together to assess standards of care at Hartford HealthCare Cancer Institute.